STEMXPAND
Live / Registered — International registration cancelled — extension of protection cancelled (as of 08 May 2022)
What this means for you
Registered since 09 Jul 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79114549
- Registration number
- 4362771
- Mark type
- Stylized text
- Filed
- 07 May 2012
- Published for opposition
- 23 Apr 2013
- Registered
- 09 Jul 2013
- Attorney of record
- Jonathan Myers
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations intended for use in cell cultures; Cell culture media for cultivating stem cells; Growth media for cell growth, namely, culture media for cultivating stem cells intended for medical biotechnology; Biological reagents for molecular biology, chemical reagents for medical use for biological methods; Growth media adapted for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; Cellular function activating agents, namely, cell growth factors and hematopoietic factors; Medicated serums, namely, human serums for cell culture; Antibodies, namely, monoclonal antibodies for the selection and purification of stem cells; All of the aforementioned goods being for medical use
- Class 010 — Medical apparatus: Medical apparatus and instruments for use in cellular therapy, medical apparatus for cell cultivation, medical instruments for cell cultivation, medical apparatus and devices intended for cell separation techniques
- Class 042 — Scientific and technological services: Research and development of new products in the field of biotechnology, scientific analysis for medical purposes and the development of new products for medical research for thirds parties
- Class 044 — Medical, beauty and agricultural services: Medical care and treatment; Medical services, namely, cell collection, isolation and growth services for medical purposes; Medical analysis in connection with the treatment of individuals, namely, in vitro diagnostic, testing and statistic analysis of the patient status for medical purposes; Therapeutic treatments
Owner
- CELLPROTHERA, FR
- CELLPROTHERA, F-68200 Mulhouse, FR
- CELLPROTHERA, F-68200 Mulhouse, FR
Prosecution history
- 26 Nov 2022 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 26 Nov 2022 — DEATH OF INTERNATIONAL REGISTRATION
- 31 Aug 2022 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 24 Aug 2022 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 04 Jul 2022 — CORRECTION TRANSACTION RECEIVED FROM IB
- 03 Jul 2022 — LIMITATION OF GOODS RECEIVED FROM IB
- 29 Jun 2022 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 29 Jun 2022 — DEATH OF INTERNATIONAL REGISTRATION
- 25 Dec 2021 — REFUSAL PROCESSED BY IB
- 28 Nov 2020 — TOTAL INVALIDATION PROCESSED BY THE IB
- 04 Nov 2020 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 03 Nov 2020 — INVALIDATION PROCESSED
- 14 Oct 2020 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 14 Feb 2020 — CANCELLED SECTION 71
- 06 Feb 2020 — NEW REPRESENTATIVE AT IB RECEIVED